Genprex reported earnings of -$ 5.30 per GNPX share on Nov 13, 2026, falling short of analysts' expectations by
| Report Date | Nov 13, 2026 |
|---|---|
| Forecasted EPS | -$ 6,160.00 |
| Earnings Per Share (Surprise) | -$ 5.30 (+$ 6,154.70) |
| Last Year's EPS | -$ 183.17 |
| EPS YoY Change |
Out of the last 47 earnings reporting periods, Genprex beat analysts’ expectations 7 times and fell short of expectations 26 time(s). Genprex reported earnings per share of -$ 5.30 in the last report surpassing an estimated EPS of -$ 6,160.00 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 6,160.00 | -$ 5.30 | -$ 109.89 | |
| Aug 14, 2026 | - | -$ 9.40 | -$ 187.00 | |
| May 13, 2026 | - | -$ 14.07 | -$ 187.00 | |
| Mar 30, 2026 | -$ 286.00 | -$ 25.30 | -$ 285.71 | |
| Nov 14, 2025 | -$ 275.00 | -$ 109.89 | -$ 25.30 | |
| Aug 14, 2025 | -$ 462.00 | -$ 187.00 | -$ 462.00 | |
| Aug 8, 2025 | -$ 15.62 | -$ 187.00 | -$ 1,351.65 | |
| May 12, 2025 | -$ 55.88 | -$ 285.71 | -$ 3,300.00 | |
| Apr 7, 2025 | -$ 18.04 | -$ 25.30 | -$ 66.00 | |
| Apr 1, 2025 | -$ 18.04 | -$ 462.00 | -$ 4,059.00 | |
| Nov 13, 2024 | -$ 1,241.76 | -$ 1,351.65 | -$ 87.12 | |
| Aug 21, 2024 | -$ 50.60 | -$ 3,300.00 | -$ 87.12 | |
| Aug 9, 2024 | -$ 50.60 | -$ 66.00 | -$ 5,714.29 | |
| May 15, 2024 | -$ 55.88 | -$ 4,059.00 | -$ 6,593.41 | |
| Apr 1, 2024 | -$ 86.46 | -$ 87.12 | -$ 8,351.65 | |
| Mar 29, 2024 | -$ 86.46 | -$ 87.12 | -$ 6,593.41 | |
| Nov 14, 2023 | -$ 2.42 | -$ 5,714.29 | -$ 114.40 | |
| Aug 21, 2023 | -$ 114.40 | -$ 6,593.41 | -$ 4,835.17 | |
| May 22, 2023 | -$ 2.64 | -$ 8,351.65 | -$ 5,274.73 | |
| Mar 31, 2023 | -$ 114.40 | -$ 6,593.41 | -$ 5,274.73 |
Genprex’s stock was trading at $ 2.21 on Nov 12, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 5.30 | $ 2.21 | ||
| Aug 14, 2026 | -$ 9.40 | $ 4.87 | $ 4.47 | |
| May 13, 2026 | -$ 14.07 | $ 18.26 | $ 18.95 | |
| Mar 30, 2026 | -$ 25.30 | $ 40.04 | $ 39.82 | |
| Nov 14, 2025 | -$ 109.89 | $ 91.08 | $ 88.88 | |
| Aug 14, 2025 | -$ 187.00 | $ 247.72 | $ 233.42 | |
| Aug 8, 2025 | -$ 187.00 | $ 243.54 | $ 234.08 | |
| May 12, 2025 | -$ 285.71 | $ 313.94 | $ 310.20 | |
| Apr 7, 2025 | -$ 25.30 | $ 368.50 | $ 280.06 | |
| Apr 1, 2025 | -$ 462.00 | $ 269.72 | $ 324.50 | |
| Nov 13, 2024 | -$ 1,351.65 | $ 2,299.00 | $ 1,804.00 | |
| Aug 21, 2024 | -$ 3,300.00 | $ 726.00 | $ 770.22 | |
| Aug 9, 2024 | -$ 66.00 | $ 1,562.00 | $ 1,386.00 | |
| May 15, 2024 | -$ 4,059.00 | $ 2,827.00 | $ 2,662.00 | |
| Apr 1, 2024 | -$ 87.12 | $ 3,278.00 | $ 3,124.00 | |
| Mar 29, 2024 | -$ 87.12 | $ 3,278.00 | $ 3,267.00 | |
| Nov 14, 2023 | -$ 5,714.29 | $ 10,076 | $ 11,440 | |
| Aug 21, 2023 | -$ 6,593.41 | $ 22,572 | $ 21,318 | |
| May 22, 2023 | -$ 8,351.65 | $ 34,100 | $ 34,584 | |
| Mar 31, 2023 | -$ 6,593.41 | $ 39,732 | $ 38,720 |
Genprex released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Genprex beat analysts’ expectations during the last earnings period by
